Structure | Chemical Name | CAS | MF |
|
N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-4-(2-fluorophenyl)-2-methyloxazole-5-carboxamide
|
2221010-42-8
|
C21H18FN3O4
|
|
2-Benzyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one
|
2221016-69-7
|
C21H24BNO3
|
|
Avanafil impurity
|
2221018-00-2
|
C30H30Cl2N6O7
|
|
Mal-PEG4-amine TFA salt
|
2221042-92-6
|
C14H24N2O6
|
|
2,6-Difluoro-3-phenylbenzaldehyde
|
2221812-11-7
|
C13H8F2O
|
|
2-(6-Bromo-2,3-difluorophenyl)-1,3-dioxolane
|
2221812-30-0
|
C9H7BrF2O2
|
|
Icotinib Impurity 7
|
2221937-43-3
|
C20H19N3O4
|
|
4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-Heptadecaoxapentapentacontanedioic acid, 1,55-bis(2,5-dioxo-1-pyrrolidinyl) ester
|
2221948-93-0
|
C46 H80 N2 O25
|
|
Bis-peg25-nhs ester
|
2221948-96-3
|
C62H112N2O33
|
|
Bis-PEG21-NHS ester
|
2221948-98-5
|
C54H96N2O29
|
|
Bis-peg13-nhs ester
|
2221949-00-2
|
C38H64N2O21
|
|
Bis-peg10-nhs ester
|
2221949-02-4
|
C32H52N2O18
|
|
1H-1,2,4-Triazol-3-amine, 5-[4-[(2S,5S)-2-[(4-chlorophenyl)methyl]-5-methyl-4-(2-methylpropyl)-1-piperazinyl]-1-piperidinyl]-
|
2221950-65-6
|
C23H36ClN7
|
|
1-benzyl-1-azaspiro[4.4]nonan-6-one
|
2221965-34-8
|
C15H19NO
|
|
(1S,6R)-8-methyl-3,8-diazabicyclo[4.2.0]octane dihydrochloride
|
2221988-52-7
|
C7H15ClN2
|
|
5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one
|
2222001-58-1
|
C28H28Cl2N2O5
|
|
Boronic acid, B-(5-chloro-4-methyl-2-thienyl)-
|
2222020-36-0
|
C5H6BClO2S
|
|
2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]-
|
2222094-18-8
|
C24H24F3NO2
|
|
(2-(difluoromethoxy)pyridin-3-yl)methanol
|
2222104-49-4
|
C7H7F2NO2
|
|
2-(difluoromethoxy)nicotinaldehyde
|
2222104-51-8
|
C7H5F2NO2
|
|
ARD-2128
|
2222111-87-5
|
C45H50ClN7O6
|
|
ARV110
|
2222112-77-6
|
C41H43ClFN9O6
|
|
Carbamic acid, N-[trans-4-(3-chloro-4-cyanophenoxy)cyclohexyl]-, 1,1-dimethylethyl ester
|
2222114-19-2
|
C18H23ClN2O3
|
|
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-fluoro-6-(1-piperazinyl)-
|
2222114-22-7
|
C17H17FN4O4
|
|
2-(2,6-DIOXOPIPERIDIN-3-YL)-5-FLUORO-6-(PIPERAZIN-1-YL)ISOINDOLINE-1,3-DIONE HCL
|
2222114-23-8
|
C17H18ClFN4O4
|
|
Cyclohexanecarboxylic acid, 4-(3-chloro-4-cyanophenoxy)-, trans-
|
2222114-60-3
|
C14H14ClNO3
|
|
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester
|
2222114-64-7
|
C22H26N4O6
|
|
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4,5-difluoro-
|
2222115-19-5
|
C13H8F2N2O4
|
|
Benzoic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methyl-, methyl ester
|
2222115-55-9
|
C15H24O3Si
|
|
4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1Hisoindol-5-yl]-, 1,1-dimethylethyl ester-1-Piperazinecarboxylic acid,
|
2222116-02-9
|
C22H25FN4O6
|
|
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester
|
2222120-27-4
|
C22H28N4O5
|
|
2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-(1-piperazinyl)-2H-isoindol-2-yl]-
|
2222120-30-9
|
C17H20N4O3
|
|
2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-(1-piperazinyl)-2H-isoindol-2-yl]-, hydrochloride (1:1)
|
2222120-31-0
|
C17H21ClN4O3
|
|
4-Bromo-9,9-dimethyl-9,10-dihydroacridine
|
2222130-32-5
|
C15H14BrN
|
|
Cyclic di-GMP (sodium salt)
|
2222132-40-1
|
C20H25N10NaO14P2
|
|
IC-BT-Br
|
2222146-77-0
|
C19H7BrN4OS
|
|
RDN-BT-Br
|
2222146-84-9
|
C12H8BrN3OS3
|
|
N-[(11bS)-2,6-bis([1,1'-biphenyl]-4-yl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoro-Methanesulfonamide
|
2222149-77-9
|
C45H30F3NO5PS-
|
|
(1S)-2-METHYL-1-(2-PYRIDYL)PROPYLAMINE DIHYDROCHLORIDE
|
2222165-17-3
|
C9H15ClN2
|
|
Fmoc-Glu(OtBu)-Glu(OtBu)-NH2
|
2222252-86-8
|
|
|
Epimedonin G
|
2222285-80-3
|
C20H18O6
|
|
Epimedonin H
|
2222285-82-5
|
C20H18O7
|
|
Epimedonin I
|
2222285-83-6
|
C21H22O8
|
|
Epimedonin J
|
2222285-84-7
|
C25H26O6
|
|
Epimedonin K
|
2222285-85-8
|
C30H34O6
|
|
5-Bromo-4-fluoro-1-methyl-1H-pyridin-2-one
|
2222300-61-8
|
C6H5BrFNO
|
|
4-Iodothieno[3,4-c]furan-1,3-dione
|
2222337-05-3
|
C6HIO3S
|
|
19,21-Dinorchol-4-en-20(22)-yn-3-one, 17-hydroxy-23,23-dimethyl-11-[4-[methyl(1-methylethyl)amino]phenyl]-, (11β,17α)-
|
2222344-98-9
|
C34H47NO2
|
|
SNIPER(ABL)-033
|
2222354-18-7
|
C61H73F3N10O9S2
|
|
Viburnumoside
|
2222365-74-2
|
C26H38O8
|
|
7β-Galloyloxysweroside
|
2222365-75-3
|
C23H26O14
|
|
7α-Galloyloxysweroside
|
2222365-76-4
|
C23H26O14
|
|
(4-methoxy-3,5-dimethylphenyl)dimethylsulfonium bis((perfluorobutyl)sulfonyl)amide
|
2222384-16-7
|
C19H17F18NO5S3
|
|
(4-methoxy-3,5-dimethylphenyl)dimethylsulfonium 4,4,5,5,6,6-hexafluoro-1,3,2-dithiazinan-2-ide 1,1,3,3-tetraoxide
|
2222384-17-8
|
C14H17F6NO5S3
|
|
2-(4-Phenoxyphenyl)-1,3,2-dioxaborinane
|
2222401-82-1
|
C15H15BO3
|
|
2222401-85-4
|
2222401-85-4
|
C11H13BO4
|
|
Ir[FCF3(CF3)ppy]2(dtbbpy)PF6
|
2222402-20-0
|
C44H34F20IrN4P
|
|
Palbociclib Impurity 61
|
2222404-53-5
|
C14H20N4O4
|
|
N-(naphthalen-1-yl)-[1,1'-binaphthalen]-4-amine
|
2222442-87-5
|
C30H21N
|
|
4,4'-(Perfluoro-1,4-phenylene)bis(1H-pyrazole)
|
2222452-42-6
|
C12H6F4N4
|
|
(1S)-2,2,2-TRIFLUORO-1-(3-METHOXYPHENYL)ETHYLAMINE HYDRICHLORIDE
|
2222471-40-9
|
C9H11ClF3NO
|
|
4-Bromo-5-methyl-1H-pyrazole-3-carbonitrile
|
2222511-91-1
|
C5H4BrN3
|
|
Boc-NH-PEG15-NH2
|
2222566-55-2
|
C37H76N2O17
|
|
DCLK1-IN-1
|
2222635-15-4
|
C26H28F3N7O2
|
|
2-Chloro-4-(difluoromethoxy)benzaldehyde
|
2222644-34-8
|
C8H5ClF2O2
|
|
2-Bromo-5-(1,1-dimethylethyl)-1,1′-biphenyl
|
2222647-28-9
|
C16H17Br
|
|
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-bromo-6-(2-hydroxy-2-methylpropoxy)-
|
2222653-73-6
|
C12H12BrN3O2
|
|
4-(6-Fluoropyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile
|
2222653-74-7
|
C17H15FN4O2
|
|
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-(6-fluoro-3-pyridinyl)-6-hydroxy-
|
2222654-09-1
|
C13H7FN4O
|
|
(S)-2,2,2-TRIFLUORO-1-(NAPHTHALEN-1-YL)ETHANAMINE HYDROCHLORIDE
|
2222662-58-8
|
C12H11ClF3N
|
|
(R)-(3-Methyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride
|
2222683-65-8
|
C10H21ClN2O2
|
|
(S)-(3-Methyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride
|
2222683-66-9
|
C10H21ClN2O2
|
|
Biotin-PEG4- Picolyl Azide
|
2222687-71-8
|
C27H42N8O7S
|
|
MorDalphos Pd G3
|
2222690-89-1
|
C43H55N2O4PPdS
|
|
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-[6-(3,6-diazabicyclo[3.1.1]hept-3-yl)-3-pyridinyl]-6-(2-hydroxy-2-methylpropoxy)-
|
2222752-05-6
|
C22H24N6O2
|
|
4-(6-(3,6-Diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile dihydrochloride
|
2222752-06-7
|
C22H25ClN6O2
|
|
LOXO-292
|
2222755-14-6
|
C29H31N9O3
|
|
3,6-Diazabicyclo[3.1.1]heptane-6-carboxylic acid, 3-[5-[3-cyano-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridin-4-yl]-2-pyridinyl]-, 1,1-dimethylethyl ester
|
2222755-94-2
|
C27H32N6O4
|
|
Methanesulfonic acid, 1,1,1-trifluoro-, 6-bromo-3-cyanopyrazolo[1,5-a]pyridin-4-yl ester
|
2222756-23-0
|
C9H3BrF3N3O3S
|
|
6-Bromo-4-(6-fluoro-3-pyridinyl)-pyrazolo[1,5-a]pyridine-3-carbonitrile
|
2222756-24-1
|
C13H6BrFN4
|
|
4-(6-Fluoropyridin-3-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
|
2222756-25-2
|
C19H18BFN4O2
|
|
2H-Pyrrolo[3,4-c]pyridine-2-carboxylic acid, 6-(chloromethyl)-1,3-dihydro-, 1,1-dimethylethyl ester
|
2222756-66-1
|
C13H17ClN2O2
|
|
tert-Butyl 3-(5-bromopyridin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate
|
2222757-10-8
|
C15H20BrN3O2
|
|
2,7-Diazaspiro[4.5]decane-7-carboxylic acid, 1,1-dimethylethyl ester, (5S)-
|
2222758-66-7
|
C13H24N2O2
|
|
Dynarrestin
|
2222768-84-3
|
C22H23F2N3O2S
|
|
[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-N,2-dimethyl-2-propanesulfinamide
|
2222798-18-5
|
C30H32NOPS
|
|
Estrogen receptor antagonist 2
|
2222844-89-3
|
C24H28F4N6
|
|
Carbamic acid, N-[1-(3-fluoropropyl)-3-azetidinyl]-, 1,1-dimethylethyl ester
|
2222845-47-6
|
C11H21FN2O2
|
|
Carbamic acid, N-[(1R)-1-methyl-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl]ethyl]-, 1,1-dimethylethyl ester
|
2222846-04-8
|
C20H29N3O3
|
|
(R)-1-(1H-indazol-4-yl)propan-2-amine dihydrochloride
|
2222846-05-9
|
C10H15Cl2N3
|
|
4,4-(9H-fluorene-0,9-diyl)bis(3,5-dimethylphenol)
|
2222861-04-1
|
C29H26O2
|
|
8H-Indeno[1,2-d]oxazole, 3a,8a-dihydro-2-(1-isoquinolinyl)-, (3aS,8aR)-
|
2222863-66-1
|
C19H14N2O
|
|
methyl 4-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopropyl)benzoate
|
2222866-66-0
|
C17H23BO4
|
|
2,2'-(cyclopropane-1,1-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
|
2222867-16-3
|
C15H28B2O4
|
|
1,3,2-Dioxaborolane-2-butanoic acid, 4,4,5,5-tetramethyl-, methyl ester
|
2222868-64-4
|
C11H21BO4
|
|
tert-butyl 3-(2-aminopyridin-4-yl)pyrrolidine-1-carboxylate
|
2222933-77-7
|
C14H21N3O2
|
|
2-bromo-5-(oxetan-3-yl)pyrazine
|
2222934-73-6
|
C7H7BrN2O
|
|
4-chloro-6-(oxetan-3-yl)pyrimidine
|
2222937-26-8
|
C7H7ClN2O
|
|
2-bromo-5-(oxetan-3-yl)pyridine
|
2222937-34-8
|
C8H8BrNO
|
|
CBP-IN-1
|
2222941-37-7
|
C30H32F2N4O3
|